Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $3.56 Million - $4.49 Million
-15,000 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $643,175 - $789,400
-2,500 Reduced 14.29%
15,000 $4.4 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $5.11 Million - $5.76 Million
17,500 New
17,500 $5.76 Million
Q2 2021

Jul 19, 2021

SELL
$225.08 - $271.69 $45.9 Million - $55.4 Million
-204,000 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$212.38 - $245.9 $7.96 Million - $9.22 Million
37,500 Added 22.52%
204,000 $45.9 Million
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $21.2 Billion - $24.5 Billion
-99,849,000 Reduced 99.83%
166,500 $37 Million
Q4 2020

Feb 11, 2021

BUY
$212.5 - $245.46 $21.2 Billion - $24.5 Billion
99,942,500 Added 136907.53%
100,015,500 $22.2 Billion
Q3 2020

Nov 13, 2020

SELL
$177.16 - $215.33 $12,755 - $15,503
-72 Reduced 0.1%
73,000 $15.7 Million
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $1.01 Million - $1.39 Million
-7,886 Reduced 9.74%
73,072 $12.9 Million
Q1 2020

May 12, 2020

SELL
$121.39 - $169.05 $97,112 - $135,240
-800 Reduced 0.98%
80,958 $11.2 Million
Q4 2019

Feb 11, 2020

BUY
$133.47 - $153.48 $3.11 Million - $3.58 Million
23,312 Added 39.89%
81,758 $12.5 Million
Q3 2019

Nov 12, 2019

BUY
$135.4 - $146.47 $7.91 Million - $8.56 Million
58,446 New
58,446 $8.44 Million
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $1.58 Million - $1.83 Million
-16,694 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$98.13 - $108.9 $1.57 Million - $1.74 Million
16,005 Added 2322.93%
16,694 $1.81 Million
Q2 2018

Aug 01, 2018

BUY
$96.1 - $103.24 $66,212 - $71,132
689 New
689 $68,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Mufg Securities Emea PLC Portfolio

Follow Mufg Securities Emea PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.